ESTABLISHMENT LABS HOLDINGS INC. 8-K

What Happened

• Establishment Labs Holdings Inc. announced on an 8-K that the Board appointed Taylor Harris as a director effective June 24, 2026. Mr. Harris will serve until the Company’s 2027 annual meeting of shareholders and until his successor is elected and qualified. The company issued a press release about the appointment on June 29, 2026.

Key Details

• Appointment date: June 24, 2026; term: through the 2027 annual meeting.
• Committee assignments: Audit Committee and Nominating & Corporate Governance Committee.
• Committee composition: Audit Committee — Ann Custin (chair), Taylor Harris, Bryan Slotkin; Nominating & Corporate Governance Committee — Leslie Gillin (chair), Taylor Harris, Bryan Slotkin.
• Director compensation: Mr. Harris will receive the company’s standard non-employee director cash and equity compensation; policy updated April 24, 2026 sets initial and annual equity grants at $170,000.
• Governance: The Board stated that members of the Audit, Compensation and Nominating & Corporate Governance Committees meet Nasdaq independence criteria. Mr. Harris executed the company’s standard indemnification agreement (previously filed).

Why It Matters

• A new director and changes to Audit Committee membership can affect corporate oversight, including financial reporting and governance review — items investors watch closely.
• The updated non-employee director equity grant amount ($170,000 for new directors and annually) is a disclosed compensation policy that could affect future equity awards and dilution expectations.
• The filing is procedural and factual (appointment, committee assignments, compensation terms); no related-party transactions or other material arrangements requiring Item 404 disclosure were reported.